Skip to main content
Log in

History of Changes in the Protocol of Clinical Trial of Zinc Supplementation in Treatment of COVID-19 by Hydroxychloroquine

  • Brief Report
  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

An article published in this journal used a randomized controlled trial to evaluate the efficacy of combining chloroquine/hydroxychloroquine (CQ/HCQ) and zinc in the treatment of COVID-19 patients. Findings from this study indicate that zinc supplements did not enhance the clinical efficacy of hydroxychloroquine in improving COVID-19 treatment. Although this finding is consistent with many previous studies, several concerns regarding study protocol and trial registration, including interventions and primary outcomes, have been raised in which the protocol has been changed after the completion of the recruitment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

Data sharing is not applicable to this article.

References

  1. Abd-Elsalam S, Soliman S, Esmail ES et al (2021) Do zinc supplements enhance the clinical efficacy of hydroxychloroquine?: a randomized, multicenter trial. Biol Trace Elem Res 199(10):3642–3646. https://doi.org/10.1007/s12011-020-02512-1

    Article  CAS  PubMed  Google Scholar 

  2. Thomas S, Patel D, Bittel B et al (2021) Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial. JAMA Netw Open 4(2):e210369

    Article  PubMed  PubMed Central  Google Scholar 

  3. Horby P, Mafham M, Linsell L et al (2020) Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 383(21):2030–2040

    Article  PubMed  Google Scholar 

  4. Krleza-Jerić K, Chan AW, Dickersin K et al (2005) Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 330(7497):956–958

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zinc with chloroquine/hydroxychloroquine in treatment of COVID-19. https://ClinicalTrials.gov/show/NCT04447534. Accessed 3 Mar 2023

Download references

Author information

Authors and Affiliations

Authors

Contributions

DS and KHH drafted the manuscript. All the authors read and approved the final manuscript.

Corresponding author

Correspondence to Dorn Sornsil.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics Approval Statement

N/A

Patient Consent Statement

N/A

Permission to Reproduce Material from Other Sources

N/A

Clinical trial registration

N/A

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sornsil, D., Harada, K.H. & Phosri, A. History of Changes in the Protocol of Clinical Trial of Zinc Supplementation in Treatment of COVID-19 by Hydroxychloroquine. Biol Trace Elem Res 202, 1926–1927 (2024). https://doi.org/10.1007/s12011-023-03807-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-023-03807-9

Keywords

Navigation